Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2025-12-25 @ 10:26 PM
NCT ID: NCT00305058
Description: None
Frequency Threshold: 0
Time Frame: 120 minutes
Study: NCT00305058
Study Brief: Trial Comparing Morphine to Hydromorphone in Elderly Patients With Severe Pain
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Morphine 0.05 mg/kg IV morphine 0 None 0 90 14 90 View
Hydromorphone 0.0075 mg/kg IV hydromorphone 0 None 0 93 23 93 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nausea None Gastrointestinal disorders None View
Vomiting None Gastrointestinal disorders None View
Systolic blood pressure <90 mmHg None Vascular disorders None View
Pruritus None Skin and subcutaneous tissue disorders None View
Respiratory rate <12 breaths/min None Respiratory, thoracic and mediastinal disorders None View
Oxygen saturation <90% None Respiratory, thoracic and mediastinal disorders None View
Oxygen saturation 90%-94% None Respiratory, thoracic and mediastinal disorders None View